Profil
Paul H.
Fischer served as the President, Chief Executive Officer & Director of GenVec, Inc. from 1996 to 2012.
Prior to that, he worked as a Manager-Cancer Research at Pfizer Inc. and as an Executive Vice President-Research & Development at Agenus, Inc. Fischer holds a doctorate from The University of California, San Francisco and an undergraduate degree from the University of Denver.
Anciens postes connus de Paul H. Fischer
| Sociétés | Poste | Fin |
|---|---|---|
| GENVEC INC | Directeur Général | 22/05/2012 |
| PFIZER, INC. | Corporate Officer/Principal | - |
| AGENUS INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Paul H. Fischer
| University of Denver | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AGENUS INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
